Verenium (VRNM +11.7%) receives EPA authorization to market its next-generation cellulase enzyme...

|About: Verenium Corporation (VRNM)|By:, SA News Editor

Verenium (VRNM +11.7%) receives EPA authorization to market its next-generation cellulase enzyme for non-food applications, including use as a biocatalyst to break down the guar-based gel used in hydraulic fracturing. VRNM estimates the addressable market in the U.S. for guar breakers in fracking is $250M.